Agitation Clinical Trial
Official title:
Quality Improving Program on Agitation in the Surgical Intensive Care Unit
Verified date | July 2014 |
Source | University Hospital, Geneva |
Contact | n/a |
Is FDA regulated | No |
Health authority | Switzerland: Federal Office of Public Health |
Study type | Interventional |
Agitation in the intensive care unit can have multiple consequences. The investigators
hypothesize that agitation and its consequences can be reduced by the introduction of a
reminder aiming at guiding the management of agitation. The investigators also hypothesize
that they can prevent agitation and its consequences by acting on patients environment with
reafferentation and relaxation methods.
The investigators' objectives are to test within a quality improvement project by a
prospective randomized study:
- If by reducing the number of agitation episodes we reduce the number of harmful
consequences.
- If the introduction of reafferentation and relaxation methods (music therapy or
reflexology) can prevent the occurrence of agitation.
- If the introduction of a reminder on management of agitation can reduce the number of
agitation episodes.
This study is conducted in an18 general surgical ICU beds receiving 1600 patients / year for
a total of 6900 hospital /days /year, in a tertiary teaching hospital.
The study is organized in 3 phases:
1. First phase: Baseline phase (Prospective analysis of the present situation)
2. Second phase: Learning phase (Implementation of a reminder about the management of
agitation and delirium )
3. Third phase: Randomized Intervention (reminder alone vs addition of music or
reflexology)
The interventions are :
1. Implementation of a reminder of guidelines of agitation diagnosis and management.
2. Music intervention( see description below) + reminder
3. Reflexology (see description below)+ reminder
Agitation is monitored with two scales SAS and CAM-ICU(description below) . Harmful
consequences and complications are systematically registered as well as medication and the
use of contention methods.
Adherence to the implemented monitoring and interventions is also regularly checked.
Data are daily collected (see details below) Statistical analysis and power calculation (see
below)
Status | Completed |
Enrollment | 1107 |
Est. completion date | January 2005 |
Est. primary completion date | January 2005 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - older than 18 years - admission in ICU >24 hours Exclusion Criteria: - amputation - paraplegia - non french speaking - consent refusal |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Switzerland | Surgical Intensive Care Unit | Geneva |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Geneva |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Effect of reminder of guidelines of agitation diagnosis (by SAS and CAM-ICU ) and management | The caregiver will be helped in the diagnosis of the cause, the management of and the treatment of agitation and delirium by a reminder. This reminder has been adapted from the guidelines from the ACCP and SCCM committee. Investigators will instruct nurses and physicians on the use of the reminder 3 times a week for 20 min during 1 month. Investigators will provide pocket reminders for every caregiver and display posters of the reminder in key points. The reminder will also be available on the intranet site and introduced in the SISIF system (bedside computerized patient chart). Measurement: At each agitation episode, the physician in charge of the patient will be asked the etiology of the agitation. The treatment chosen according to this diagnosis will be compared to the treatment proposed in the reminder. The percentage of treatment conforming to the reminder will be considered as the adherence to the reminder. |
lenght of patients' stay, 3.5 days on average | No |
Primary | Diminution of agitation (SAS and CAM-ICU) trough a music intervention or reflexology | Music intervention: The patient will listen to a variety of music for at least 20 minutes in the morning and in the afternoon (compact disc players with headphones with disposable ear pads). The preferred music will be freely available for the rest of the day. The choice of the music type will depend on the patients ability to communicate his desires. If the patient is not able to express his choice, the caregiver will ask his next of kin. If the information is not available, the caregiver will select a type of music he judges adapted to the patient's situation. Reflexology: This therapy will be applied 20 minutes per day to patients by a certified specialist in reflexologic massages. Measurements : Investigators analyze the presence or absence of agitation and delirium by SAS and CAM-ICU at each evaluation judged necessary by the nurse, at least once by shift (every 8 hours). |
lenght of patients' stay, 3.5 days on average | No |
Secondary | Correlation between the reduction of the number of agitation episodes (SAS and CAM-ICU) and the number of harmful consequences | Complications : Investigators will register the events related to an agitation episode or delirium and classify them in three groups determined by the potential life threatening character of the event. One event can be considered as severe i.e. really life threatening (self extubation, ventilator disconnection, central catheter removal, chest tube removal, trauma, falling from bed), moderate (removal of nasogastric tube, peripheral venous or arterial catheter) or mild i.e. not life threatening (contortion of the patient in his bed, patient's aggressiveness toward the staff, urethral catheter removal, electrode or saturation monitoring removal). Medication : Investigators will register the patient's medication in a daily total dose (mg /patient/day/drug) of 3 drug groups in relation with agitation (sedatives, analgesics, antipsychotics). The use of contention methods will be registered will be compared for each phase of the study. |
lenght of patients' stay, 3.5 days on average | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02525991 -
Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting
|
Phase 4 | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Completed |
NCT01976754 -
Safety Study of Dexmedetomidine in Septic Patients
|
N/A | |
Completed |
NCT01217541 -
Collaboration Between Department of Old Age Psychiatry and Nursing Homes
|
N/A | |
Withdrawn |
NCT00786318 -
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
|
Phase 4 | |
Not yet recruiting |
NCT05974527 -
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
|
Phase 4 | |
Not yet recruiting |
NCT05522647 -
Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.
|
||
Recruiting |
NCT02590744 -
Effects of Preoperative Using of Eye Patches on Prevention of Emergence Agitation After Cataract Surgery
|
N/A | |
Recruiting |
NCT02164773 -
Addition of Magnesium Sulfate to Caudal to Prevent Postoperative Emergence Agitation.
|
Phase 4 | |
Completed |
NCT01524367 -
Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery
|
Phase 4 | |
Completed |
NCT01501123 -
Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient
|
N/A | |
Completed |
NCT01021696 -
Pain in Patients With Dementia and Behavioural Disturbances
|
Phase 2/Phase 3 | |
Recruiting |
NCT05397639 -
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
|
Phase 3 | |
Terminated |
NCT03044249 -
A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
|
Phase 2 | |
Completed |
NCT05165914 -
Midazolam Effect on Agitation Postnasal Surgery
|
N/A | |
Completed |
NCT04010305 -
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
|
Phase 1 | |
Completed |
NCT02720705 -
Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children
|
Phase 2/Phase 3 | |
Completed |
NCT02428283 -
Scalp Nerve Block on Emergence Agitation
|
Phase 4 | |
Completed |
NCT00457366 -
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
|
Phase 4 | |
Terminated |
NCT00315900 -
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
|
Phase 3 |